143 related articles for article (PubMed ID: 21942635)
1. Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
Bolchi C; Gotti C; Binda M; Fumagalli L; Pucci L; Pistillo F; Vistoli G; Valoti E; Pallavicini M
J Med Chem; 2011 Nov; 54(21):7588-601. PubMed ID: 21942635
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists.
Bolchi C; Valoti E; Gotti C; Fasoli F; Ruggeri P; Fumagalli L; Binda M; Mucchietto V; Sciaccaluga M; Budriesi R; Fucile S; Pallavicini M
J Med Chem; 2015 Aug; 58(16):6665-77. PubMed ID: 26225816
[TBL] [Abstract][Full Text] [Related]
3. 5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
Pallavicini M; Bolchi C; Binda M; Cilia A; Clementi F; Ferrara R; Fumagalli L; Gotti C; Moretti M; Pedretti A; Vistoli G; Valoti E
Bioorg Med Chem Lett; 2009 Feb; 19(3):854-9. PubMed ID: 19097783
[TBL] [Abstract][Full Text] [Related]
4. From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor.
Bolchi C; Bavo F; Gotti C; Fumagalli L; Fasoli F; Binda M; Mucchietto V; Sciaccaluga M; Plutino S; Fucile S; Pallavicini M
Eur J Med Chem; 2017 Jan; 125():1132-1144. PubMed ID: 27810599
[TBL] [Abstract][Full Text] [Related]
5. Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 Subtype.
Bavo F; Pallavicini M; Gotti C; Appiani R; Moretti M; Colombo SF; Pucci S; Viani P; Budriesi R; Renzi M; Fucile S; Bolchi C
J Med Chem; 2020 Dec; 63(24):15668-15692. PubMed ID: 33325696
[TBL] [Abstract][Full Text] [Related]
6. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Mihalak KB; Carroll FI; Luetje CW
Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
[TBL] [Abstract][Full Text] [Related]
7. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and alpha4beta2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes.
Pallavicini M; Moroni B; Bolchi C; Cilia A; Clementi F; Fumagalli L; Gotti C; Meneghetti F; Riganti L; Vistoli G; Valoti E
Bioorg Med Chem Lett; 2006 Nov; 16(21):5610-5. PubMed ID: 16942873
[TBL] [Abstract][Full Text] [Related]
10. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
12. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
13. (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
Tatsumi R; Fujio M; Takanashi S; Numata A; Katayama J; Satoh H; Shiigi Y; Maeda J; Kuriyama M; Horikawa T; Murozono T; Hashimoto K; Tanaka H
J Med Chem; 2006 Jul; 49(14):4374-83. PubMed ID: 16821797
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligands.
Scanio MJ; Shi L; Bunnelle WH; Anderson DJ; Helfrich RJ; Malysz J; Thorin-Hagene KK; Van Handel CE; Marsh KC; Lee CH; Gopalakrishnan M
J Med Chem; 2011 Nov; 54(21):7678-92. PubMed ID: 21962147
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
[TBL] [Abstract][Full Text] [Related]
16. 7-Azaindole derivatives as potential partial nicotinic agonists.
Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG
Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307
[TBL] [Abstract][Full Text] [Related]
17. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
[TBL] [Abstract][Full Text] [Related]
18. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
Papke RL; Schiff HC; Jack BA; Horenstein NA
Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR
J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
